Adjusted EBITDA times a multiple gives the enterprise value; the debt, fees and rollover decide what the owner actually receives.
An optometry practice is worth its adjusted EBITDA times a multiple, less the debt repaid at closing, with fees and any rollover taken from the equity. In the book's fictional case a consolidator offered 6.0 times $372,534, an enterprise value of $2,235,204, which left the owner $516,290 of cash at closing.
Worked in full in The Optometry Practice Owner by Julian R. Sterling.Get the DRM-free PDF, $19.99 →or the paperback
Free: the Optometry Practice Revenue per Patient and Break-Even Calculator, an Excel workbook that returns revenue per patient seen, the optical gross margin, the exams a month to break even and what ten more points of capture are worth.
An optometry practice is worth its earnings times a multiple, and the first question is which earnings. Seller's discretionary earnings (SDE) are EBITDA plus the owner's salary and its burden: earnings before any pay to the owner. An optometrist who will buy the practice and work in it reads SDE, because she will replace the owner's chair with her own. Adjusted EBITDA is SDE less the market cost of an optometrist to do the owner's clinical days. A group that must pay someone to see those patients reads that.
In the book's fictional case, Orvanell Eye Care, the market cost is set at $190,655 a year (a salary of $170,000 plus burden). SDE was $395,743 in FY2025 and $546,019 in FY2026; adjusted EBITDA $205,088 and $355,364. No market multiple is quoted here, because none was verified from a primary source; the multiple below is the buyer's figure in a fictional letter of intent.
The trap: an SDE figure multiplied by an EBITDA multiple. The owner's pay is then both added back and still owed to whoever does her work. In the case, applying the letter's 6.0 times to SDE of $546,019 instead of adjusted EBITDA would give $3,276,114, $1,040,910 more, mostly for earnings that go to the owner's salary after the sale.
On 8 October 2026 a group of eye care practices backed by a private equity fund (a consolidator, not named) sent the owner a letter of intent. Its arithmetic:
| Line | Amount |
|---|---|
| FY2026 EBITDA | $384,523 |
| Add back: the owner's salary and burden | $161,496 |
| SDE | $546,019 |
| Less: market cost of an optometrist for the owner's clinical days | −$190,655 |
| Add back: second site pre-opening costs, treated as one-time | $17,170 |
| Adjusted EBITDA | $372,534 |
Enterprise value = $372,534 × 6.0 = $2,235,204, which is 4.09 times SDE (a ratio the buyer does not use)
The structure depends on the state. In the letter, the group's management company would buy the non-clinical assets and a professional entity owned by a licensed optometrist would take the patient records and the clinical practice, paying the management company under a management services agreement. Whether that is permitted, and in what form, is for counsel in the practice's state.
The book goes further: seven Excel workbooks (revenue per patient, capture and optical margin, associate pay, OCT buy or lease, break-even, purchase and SBA loan, offer to cash), each with an exercise and its answer. See The Optometry Practice Owner · PDF, $19.99
A buyer reads more than one line of earnings. In the case the owner produced $420,277 of the $882,912 of professional fees in FY2026, 47.6%: the more of the practice sits in her chair, the more the buyer must pay to replace her and the more it will want her to stay. Medical visits were 32.5% of FY2026 encounters and vision plans and insurers paid 40.4% of revenue, the payer mix a buyer tests for quality of revenue. The second site, still losing money over its first seven months, contributed $31,531 in its fourth quarter, the evidence a buyer reads for growth.
Enterprise value is not what the owner receives. The letter is cash-free and debt-free: every loan is repaid from the price, fees come off, and part of the equity is rolled into the buyer.
| Line | Amount |
|---|---|
| Enterprise value | $2,235,204 |
| SBA loan for the purchase repaid | −$888,786 |
| SBA loan for the second site repaid | −$273,339 |
| OCT loan and equipment lease repaid | −$208,046 |
| Seller note with accrued interest repaid | −$62,140 |
| Equity value | $802,893 |
| Transaction fees (2.5% of enterprise value + $30,000 legal) | −$85,880 |
| Rollover, 25% of equity value, into the group's holding company | −$200,723 |
| Cash to the owner at closing | $516,290 |
Outside the price, the PLLC keeps its own cash ($97,989) and collects its receivables ($80,488). The rollover is equity in the buyer's holding company, not cash, and is worth what that company is worth when it is sold; the article on how rollover equity is calculated covers the mechanics. Once the loans are repaid, the owner's personal guarantees end with them.
After the sale the owner would work for the professional entity at $190,655 with burden, exactly the market cost already deducted from SDE: her future pay is a cost of the buyer, counted once, and neither part of the price nor taken twice. Any non-compete in the purchase or employment agreement is a matter of state law.
Half a turn of multiple moves the owner's cash far more than the price, because the debt does not shrink with it:
| Line | 6.0 times | 5.5 times |
|---|---|---|
| Enterprise value | $2,235,204 | $2,048,937 |
| Debt repaid | $1,432,311 | $1,432,311 |
| Fees | $85,880 | $81,223 |
| Rollover | $200,723 | $154,157 |
| Cash at closing | $516,290 | $381,246 |
The price fell by 8.3% and the cash at closing by 26.2%.
An individual buyer financing with a 7(a) loan would face the SBA's SOP 50 10 8.1, effective 1 October 2026: an equity injection of at least 10% of total project cost, seller debt counted only on full standby, and limited sources providing no more than half of it. On the letter's price alone, 10% is $223,520 and half of that $111,760, before working capital and closing costs. That buyer would also price SDE, not adjusted EBITDA, and the lender's coverage test would decide how much of it the loan could carry.
Rules checked on 17 November 2026, federal only, and not legal, tax, accounting or clinical advice. Orvanell Eye Care, its bank, lessor, landlord and buyer are fictional: every case figure is a teaching assumption, not a market norm. State law is for counsel in the practice's state.
No market multiple is given here, because none was verified from a primary source; buyers set it from size, growth, the owner's share of production, the payer mix and risk. In the book's fictional letter of intent a consolidator offered 6.0 times adjusted EBITDA.
An optometrist who will work in the practice reads SDE, which adds back the owner's pay. A group reads adjusted EBITDA, SDE less the market cost of an optometrist. In the case SDE was $546,019 and the buyer's adjusted EBITDA $372,534.
Because the loans are repaid from the price, fees are paid and part of the equity is rolled into the buyer. In the case an enterprise value of $2,235,204 left $516,290 of cash at closing, plus a rollover of $200,723.
Often, under an employment agreement. In the case the owner would keep her 18 clinic days a month at $190,655 with burden, the same cost the buyer deducted from SDE, so her salary is not paid for twice.
This article is one chapter's worth of arithmetic from The Optometry Practice Owner, which follows one fictional two-site practice for 24 months: the purchase with an SBA 7(a) loan, routine exams and medical visits, vision plans and medical insurance, the optical and its capture rate, associate pay, an OCT bought or leased, break-even, a second location and a consolidator's letter of intent.
DRM-free PDF, $19.99 · Paperback, $32.99, shipped worldwide · Free calculator